HCID 13486182, Verbindung → ethyl {2-[5-(tert-butylsulfamoyl)pyridin-2-yl]-3-oxo-2,3-dihydro-1H-pyrazol-4-yl}-(phenyl)acetate
Reaktionsgleichung
[CH:1]([CH:3]([CH:9]([C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1)[C:10]([O:12][CH2:13][CH3:14])=[O:11])[C:4]([O:6]CC)=O)=O.[C:21]([NH:25][S:26]([C:29]1[CH:30]=[N:31][C:32]([NH:35][NH2:36])=[CH:33][CH:34]=1)(=[O:28])=[O:27])([CH3:24])([CH3:23])[CH3:22].C(NS(C1C=CC(N2C(=O)C(C(C3C=CC=CC=3)C(OC)=O)=CN2)=NC=1)(=O)=O)(C)(C)C>>[C:21]([NH:25][S:26]([C:29]1[CH:34]=[CH:33][C:32]([N:35]2[C:4](=[O:6])[C:3]([CH:9]([C:15]3[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=3)[C:10]([O:12][CH2:13][CH3:14])=[O:11])=[CH:1][NH:36]2)=[N:31][CH:30]=1)(=[O:28])=[O:27])([CH3:24])([CH3:22])[CH3:23]Komponenten
4
Edukt 3
Produkt 1
Versuchsvorschrift
According to the process described in Example 27.2, starting with 2 g (7.19 mmol) of diethyl 2-formyl-3-phenylbutanedioate and 1.75 g (7.19 mmol) of N-tert-butyl-6-hydrazinylpyridine-3-sulfonamide, 3.1 g of methyl {2-[5-(tert-butylsulfamoyl)pyridin-2-yl]-3-oxo-2,3-dihydro-1H-pyrazol-4-yl}(phenyl)acetate are obtained in the form of a powder.